Researchers from the University of East Anglia and biotechnology company Oxford Biodynamics have developed a new blood test for diagnosing ME/CFS with 96% accuracy.

The results of this trial do not support individualizing blood pressure targets based on preoperative nighttime mean arterial pressure in high-risk patients undergoing abdominal surgery.

The new guidelines encourage patients to reduce or eliminate alcohol consumption entirely, compared with the old guidelines.